Institute of Environmental Engineering, ETH Zürich, Zürich 8093, Switzerland.
Laboratory for Advanced Analytical Technologies, Empa, Swiss Federal Laboratories for Materials Science and Technology, Dübendorf 8600, Switzerland.
ACS Nano. 2020 May 26;14(5):5268-5277. doi: 10.1021/acsnano.0c02439. Epub 2020 Apr 13.
The ongoing outbreak of the novel coronavirus disease (COVID-19) has spread globally and poses a threat to public health in more than 200 countries. Reliable laboratory diagnosis of the disease has been one of the foremost priorities for promoting public health interventions. The routinely used reverse transcription polymerase chain reaction (RT-PCR) is currently the reference method for COVID-19 diagnosis. However, it also reported a number of false-positive or -negative cases, especially in the early stages of the novel virus outbreak. In this work, a dual-functional plasmonic biosensor combining the plasmonic photothermal (PPT) effect and localized surface plasmon resonance (LSPR) sensing transduction provides an alternative and promising solution for the clinical COVID-19 diagnosis. The two-dimensional gold nanoislands (AuNIs) functionalized with complementary DNA receptors can perform a sensitive detection of the selected sequences from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through nucleic acid hybridization. For better sensing performance, the thermoplasmonic heat is generated on the same AuNIs chip when illuminated at their plasmonic resonance frequency. The localized PPT heat is capable to elevate the hybridization temperature and facilitate the accurate discrimination of two similar gene sequences. Our dual-functional LSPR biosensor exhibits a high sensitivity toward the selected SARS-CoV-2 sequences with a lower detection limit down to the concentration of 0.22 pM and allows precise detection of the specific target in a multigene mixture. This study gains insight into the thermoplasmonic enhancement and its applicability in the nucleic acid tests and viral disease diagnosis.
新型冠状病毒病(COVID-19)的持续爆发已在全球范围内蔓延,对 200 多个国家的公共卫生构成威胁。对疾病进行可靠的实验室诊断一直是促进公共卫生干预措施的首要任务之一。常规使用的逆转录聚合酶链反应(RT-PCR)是 COVID-19 诊断的参考方法。然而,它也报告了一些假阳性或假阴性病例,尤其是在新型病毒爆发的早期阶段。在这项工作中,一种结合等离子体光热(PPT)效应和局域表面等离子体共振(LSPR)传感转换的双功能等离子体生物传感器为临床 COVID-19 诊断提供了一种替代且有前途的解决方案。功能化互补 DNA 受体的二维金纳米岛(AuNIs)可通过核酸杂交对严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)的选定序列进行灵敏检测。为了获得更好的传感性能,当在等离子体共振频率下照射时,同一 AuNIs 芯片上会产生热等离子体热。局部 PPT 热能够升高杂交温度,有助于准确区分两个相似的基因序列。我们的双功能 LSPR 生物传感器对所选 SARS-CoV-2 序列具有高灵敏度,检测下限低至 0.22 pM,并允许在多基因混合物中精确检测特定靶标。这项研究深入了解了热等离子体增强及其在核酸检测和病毒疾病诊断中的适用性。